847.05
price down icon1.74%   -15.00
after-market Handel nachbörslich: 847.00 -0.05 -0.01%
loading

Argen X Se Adr Aktie (ARGX) Neueste Nachrichten

pulisher
07:11 AM

BofA Securities raises argenx stock price target to $1,006 on strong Vyvgart outlook - Investing.com

07:11 AM
pulisher
03:50 AM

Baird downgrades argenx stock rating to Neutral on valuation concerns - Investing.com

03:50 AM
pulisher
Dec 17, 2025

Argenx stock price target raised to $925 from $860 at RBC Capital - Investing.com

Dec 17, 2025
pulisher
Dec 15, 2025

Argenx stock rating maintained at Buy by BofA despite TED trial failure - Investing.com South Africa

Dec 15, 2025
pulisher
Dec 15, 2025

Jefferies maintains Buy rating on argenx stock despite failed TED trial - Investing.com

Dec 15, 2025
pulisher
Dec 15, 2025

argenx stock rating reiterated at Buy by Guggenheim despite TED study halt - Investing.com South Africa

Dec 15, 2025
pulisher
Dec 15, 2025

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Sahm

Dec 15, 2025
pulisher
Dec 15, 2025

Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

argenx stock tumbles after discontinuing thyroid eye disease studies - Investing.com

Dec 15, 2025
pulisher
Dec 11, 2025

Stifel raises argenx stock price target to $1,248 on Vyvgart dominance By Investing.com - Investing.com South Africa

Dec 11, 2025
pulisher
Dec 11, 2025

Stifel raises argenx stock price target to $1,248 on Vyvgart dominance - Investing.com India

Dec 11, 2025
pulisher
Dec 09, 2025

Argenx price target raised to $910 from $800 at UBS on Vyvgart growth By Investing.com - Investing.com South Africa

Dec 09, 2025
pulisher
Dec 09, 2025

Argenx price target raised to $910 from $800 at UBS on Vyvgart growth - Investing.com India

Dec 09, 2025
pulisher
Dec 08, 2025

DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Dec 08, 2025
pulisher
Dec 03, 2025

Argenx NV ADR stock hits all-time high at $934.62 - Investing.com India

Dec 03, 2025
pulisher
Dec 03, 2025

Argenx NV ADR stock hits all-time high at $934.62 By Investing.com - Investing.com South Africa

Dec 03, 2025
pulisher
Nov 28, 2025

If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today - Sahm

Nov 28, 2025
pulisher
Nov 25, 2025

ClearBridge International Growth ADR ESG Portfolios Q3 2025 Commentary - Seeking Alpha

Nov 25, 2025
pulisher
Nov 24, 2025

This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Nov 24, 2025
pulisher
Nov 19, 2025

Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales By Investing.com - Investing.com South Africa

Nov 19, 2025
pulisher
Nov 19, 2025

Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales - Investing.com India

Nov 19, 2025
pulisher
Nov 19, 2025

Quant Ratings Updated on 141 Stocks - InvestorPlace

Nov 19, 2025
pulisher
Nov 18, 2025

Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Nov 18, 2025
pulisher
Nov 18, 2025

argenx Announces Results of Extraordinary General Meeting of Shareholders - Sahm

Nov 18, 2025
pulisher
Nov 17, 2025

Argenx stock reaches all-time high at 915.55 USD By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

Argenx stock reaches all-time high at 915.55 USD - Investing.com

Nov 17, 2025
pulisher
Nov 17, 2025

Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN

Nov 17, 2025
pulisher
Nov 07, 2025

Argenx NV ADR stock hits all-time high of 855.68 USD - Investing.com Nigeria

Nov 07, 2025
pulisher
Nov 06, 2025

Argenx NV ADR stock hits all-time high of 855.68 USD By Investing.com - Investing.com South Africa

Nov 06, 2025
pulisher
Nov 06, 2025

Janus Henderson Global Life Sciences Fund Q3 2025 Commentary - Seeking Alpha

Nov 06, 2025
pulisher
Nov 05, 2025

argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada - Barchart.com

Nov 05, 2025
pulisher
Nov 04, 2025

Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View - Finviz

Nov 04, 2025
pulisher
Nov 04, 2025

Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales By Investing.com - Investing.com South Africa

Nov 04, 2025
pulisher
Nov 04, 2025

Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales - Investing.com

Nov 04, 2025
pulisher
Nov 03, 2025

Vyvgart Fuels Strong Growth for Argenx and Supports Developing Pipeline - Morningstar

Nov 03, 2025
pulisher
Oct 31, 2025

argenx SE stock price target raised to $1,146 from $800 at TD Cowen By Investing.com - Investing.com South Africa

Oct 31, 2025
pulisher
Oct 31, 2025

argenx SE stock price target raised to $1,146 from $800 at TD Cowen - Investing.com India

Oct 31, 2025
$396.04
price up icon 1.00%
$166.55
price down icon 16.08%
biotechnology ONC
$307.02
price up icon 0.32%
$748.71
price down icon 0.14%
$91.46
price down icon 0.15%
Kapitalisierung:     |  Volumen (24h):